Cardiac Diagnostics

In the current era of healthcare reform with the overarching goal of reducing healthcare costs, heart failure (HF) management has taken center stage. It is the leading cause of hospitalization for adults over the age of 65 in the United States and...

Medtronic Inc. announced results from the CRYSTAL AF (CRYptogenic STroke And underLying Atrial Fibrillation) clinical trial, published in The New England Journal of Medicine. The trial found that continuous cardiac monitoring with the Reveal XT in...

June 5, 2014 — New measures of the severity of coronary artery blockages do not provide enough accuracy to guide treatment decisions, according to the results of the VERIFY-2 study presented as a late-breaking clinical trial at the Society for Car...

St. Jude Medical announced the completion of its acquisition of the privately held CardioMEMS Inc., developer of the CardioMEMS heart failure (HF) management system. The acquisition was completed on May 30, 2014.

July 24, 2014 — Boston Scientific has initiated full commercial launch of its new Polaris imaging system. This system will support the Boston Scientific family...
EndoPAT diagnostic device
Data from a new study indicate that the results of an FDA-approved test for endothelial (arterial) function significantly correlated with near-future...
heart attacks, women's health
A new look at hospital data shows women have longer hospital stays and are more likely than men to die in the hospital after a heart attack.
July 18, 2014 — AliveCor announced that more than one million ECGs (electrocardiograms) have been recorded using the AliveCor heart monitor since the...
Boston Scientific's Polaris imaging system supports the family of intravascular ultrasound (IVUS) catheters, including coronary, peripheral
Boston Scientific received U.S. Food and Drug Administration (FDA) approval for the Rebel platinum chromium coronary stent system, the...
The Freedom portable driver is U.S. Food and Drug Administration (FDA)-approved for use with the SynCardia temporary total artificial heart...
Cordis Corp.'s Saber PTA (percutaneous transluminal angioplasty) dilatation catheter is for the treatment of patients with peripheral...

Articles

In the current era of healthcare reform with the overarching goal of reducing healthcare costs, heart failure (HF) management has taken center stage. It is the...
LipoScience Inc. announced the publication of the first large-scale real world study evidencing a link between low LDL-P and reduced cardiovascular disease (...
June 5, 2014 — New measures of the severity of coronary artery blockages do not provide enough accuracy to guide treatment decisions, according to the results...
St. Jude Medical announced the completion of its acquisition of the privately held CardioMEMS Inc., developer of the CardioMEMS heart failure (HF)...

Video Center

The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
4 hours 31 min ago
A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost...
2 weeks 1 day ago
There were several new cardiovascular ultrasound technology advances highlighted at the American...
3 weeks 1 day ago
CVIS, cardiovascular information system, webinar
Join Ascendian Healthcare Consulting and GE Healthcare during a webinar Wednesday, July 16 to learn about the access, productivity, and revenue cycle efficiency benefits of a modern cardiovascular...
The webinar "Implementing Robotic PCI — Why and How to Start a Successful Program" defines optimal strategies for launching a successful robotic percutaneous coronary intervention (PCI) program. The...
This webinar focuses on implementation of different strategies to help clinicians reduce radiation exposure during interventional cardiology procedures, both for patient and operators. It offers an...